Chinese venture capital firm Qiming Venture Partners is planning to raise US$250 million for its second healthcare-focused fund to finance early-stage companies in the United States, according to a regulatory document filed on January 30.
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Read 3 Articles for Free with a Basic Account
Gain limited and restricted access to China Money Network.Register Basic Account
Subscribe for an annual subscription for $359
Enjoy comprehensive and exclusive data you can't find elsewhere!Subscribe for $359
Already have an account or paid subscription?